Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Crucell, Talecris Biotherapeutics Sign License Agreement | Contract Pharma

What are you searching for?

Sign in
Breaking News

Crucell, Talecris Biotherapeutics Sign License Agreement

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Crucell has signed an exclusive, commercial license agreement with NC-based Talecris Biotherapeutics for an undisclosed protein to be produced using the PER.C6 cell line. Crucell will receive an upfront payment of $2.5 million and will be eligible for milestone payments of approximately $30 million across multiple indications. Further details were not disclosed.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters